Analytical Data
-
基因名
LRRC31
- Application
-
别名
LRRC31; UNQ9367/PRO34156Leucine-rich repeat-containing protein 31
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6UY01
-
表达区间
1-552aa
-
氨基酸序列
MSQTRKKTSSEGETKPQTSTVNKFLRGSNAESRKEDNDLKTSDSQPSDWIQKTATSETAKPLSSEMEWRSSMEKNEHFLQKLGKKAVNKCLDLNNCGLTTADMKEMVALLPFLPDLEELDISWNGFVGGTLLSITQQMHLVSKLKILRLGSCRLTTDDVQALGEAFEMIPELEELNLSWNSKVGGNLPLILQKFQKGSKIQMIELVDCSLTSEDGTFLGQLLPMLQSLEVLDLSINRDIVGSLNSIAQGLKSTSNLKVLKLHSCGLSQKSVKILDAAFRYLGELRKLDLSCNKDLGGGFEDSPAQLVMLKHLQVLDLHQCSLTADDVMSLTQVIPLLSNLQELDLSANKKMGSSSENLLSRLRFLPALKSLVINNCALESETFTALAEASVHLSALEVFNLSWNKCVGGNLKLLLETLKLSMSLQVLRLSSCSLVTEDVALLASVIQTGHLAKLQKLDLSYNDSICDAGWTMFCQNVRFLKELIELDISLRPSNFRDCGQWFRHLLYAVTKLPQITEIGMKRWILPASQEEELECFDQDKKRSIHFDHGGFQ
-
分子量
60.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC31 (Leucine-Rich Repeat Containing 31) is a protein that has gained attention in recent years due to its potential role in various biological processes and its implications in disease mechanisms. It is characterized by the presence of multiple leucine-rich repeats, which are often involved in protein-protein interactions. Studies have suggested that LRRC31 may play a significant role in cellular signaling pathways, impacting processes such as cell proliferation, differentiation, and apoptosis. Furthermore, dysregulation of LRRC31 has been linked to several pathological conditions, including cancer and autoimmune diseases, making it a candidate for therapeutic intervention. Research into recombinant LRRC31 involves the expression and purification of this protein to study its structure, functional properties, and interactions with other biomolecules. Understanding these aspects could elucidate its biological functions and pave the way for developing targeted therapies. Investigating LRRC31 at the molecular level is crucial for uncovering its role in health and disease, potentially leading to novel approaches in medical science. As research progresses, LRRC31 may emerge as a significant biomarker or therapeutic target, underscoring the importance of its recombinant protein studies in advancing our understanding of complex biological systems.
